ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/18 | 4,050 | 4,120 | 4,010 | 4,090 | +50 | +1.2% | 254,100 |
2018/05/17 | 4,035 | 4,050 | 4,005 | 4,040 | +30 | +0.7% | 135,800 |
2018/05/16 | 3,930 | 4,035 | 3,920 | 4,010 | +70 | +1.8% | 304,700 |
2018/05/15 | 3,975 | 4,015 | 3,930 | 3,940 | +25 | +0.6% | 372,700 |
2018/05/14 | 3,905 | 3,930 | 3,875 | 3,915 | +45 | +1.2% | 265,900 |
2018/05/11 | 3,865 | 3,900 | 3,830 | 3,870 | -65 | -1.7% | 309,000 |
2018/05/10 | 3,945 | 3,955 | 3,885 | 3,935 | +15 | +0.4% | 219,800 |
2018/05/09 | 3,960 | 3,980 | 3,885 | 3,920 | -80 | -2% | 266,200 |
2018/05/08 | 4,000 | 4,010 | 3,925 | 4,000 | -10 | -0.2% | 308,800 |
2018/05/07 | 3,970 | 4,015 | 3,965 | 4,010 | +50 | +1.3% | 307,600 |
2018/05/02 | 3,935 | 3,970 | 3,920 | 3,960 | +35 | +0.9% | 206,900 |
2018/05/01 | 3,930 | 3,940 | 3,910 | 3,925 | -55 | -1.4% | 187,000 |
2018/04/27 | 3,955 | 3,985 | 3,935 | 3,980 | +40 | +1% | 302,200 |
2018/04/26 | 3,915 | 3,950 | 3,850 | 3,940 | +5 | +0.1% | 220,600 |
2018/04/25 | 3,895 | 3,940 | 3,870 | 3,935 | +40 | +1% | 357,500 |
2018/04/24 | 3,845 | 3,895 | 3,835 | 3,895 | +35 | +0.9% | 188,000 |
2018/04/23 | 3,845 | 3,890 | 3,820 | 3,860 | +15 | +0.4% | 241,400 |
2018/04/20 | 3,855 | 3,880 | 3,840 | 3,845 | +5 | +0.1% | 172,800 |
2018/04/19 | 3,820 | 3,880 | 3,805 | 3,840 | +35 | +0.9% | 208,600 |
2018/04/18 | 3,815 | 3,830 | 3,750 | 3,805 | -50 | -1.3% | 243,800 |
2018/04/17 | 3,860 | 3,900 | 3,845 | 3,855 | ±0 | ±0% | 238,600 |
2018/04/16 | 3,760 | 3,860 | 3,760 | 3,855 | +105 | +2.8% | 232,200 |
2018/04/13 | 3,725 | 3,770 | 3,705 | 3,750 | +40 | +1.1% | 243,600 |
2018/04/12 | 3,710 | 3,735 | 3,695 | 3,710 | ±0 | ±0% | 138,900 |
2018/04/11 | 3,775 | 3,775 | 3,705 | 3,710 | -65 | -1.7% | 172,800 |
2018/04/10 | 3,805 | 3,810 | 3,740 | 3,775 | -35 | -0.9% | 269,200 |
2018/04/09 | 3,780 | 3,825 | 3,755 | 3,810 | +30 | +0.8% | 171,800 |
2018/04/06 | 3,735 | 3,800 | 3,710 | 3,780 | +50 | +1.3% | 299,800 |
2018/04/05 | 3,720 | 3,745 | 3,655 | 3,730 | +50 | +1.4% | 195,200 |
2018/04/04 | 3,680 | 3,700 | 3,630 | 3,680 | +15 | +0.4% | 148,300 |
2018/04/03 | 3,655 | 3,675 | 3,595 | 3,665 | -40 | -1.1% | 205,600 |
2018/04/02 | 3,685 | 3,750 | 3,680 | 3,705 | +50 | +1.4% | 191,900 |
2018/03/30 | 3,680 | 3,685 | 3,585 | 3,655 | -20 | -0.5% | 201,800 |
2018/03/29 | 3,670 | 3,690 | 3,645 | 3,675 | +35 | +1% | 149,300 |
2018/03/28 | 3,620 | 3,645 | 3,585 | 3,640 | -20 | -0.5% | 130,900 |
2018/03/27 | 3,580 | 3,665 | 3,570 | 3,660 | +85 | +2.4% | 214,100 |
2018/03/26 | 3,570 | 3,610 | 3,505 | 3,575 | -65 | -1.8% | 278,700 |
2018/03/23 | 3,695 | 3,740 | 3,630 | 3,640 | -125 | -3.3% | 240,000 |
2018/03/22 | 3,695 | 3,770 | 3,675 | 3,765 | +70 | +1.9% | 173,300 |
2018/03/20 | 3,720 | 3,735 | 3,670 | 3,695 | -55 | -1.5% | 189,700 |
2018/03/19 | 3,730 | 3,815 | 3,715 | 3,750 | -20 | -0.5% | 295,600 |
2018/03/16 | 3,750 | 3,805 | 3,745 | 3,770 | +70 | +1.9% | 291,500 |
2018/03/15 | 3,710 | 3,710 | 3,635 | 3,700 | -45 | -1.2% | 205,500 |
2018/03/14 | 3,780 | 3,785 | 3,730 | 3,745 | -25 | -0.7% | 208,200 |
2018/03/13 | 3,740 | 3,775 | 3,740 | 3,770 | -10 | -0.3% | 200,800 |
2018/03/12 | 3,720 | 3,790 | 3,710 | 3,780 | +85 | +2.3% | 226,800 |
2018/03/09 | 3,760 | 3,785 | 3,670 | 3,695 | -25 | -0.7% | 306,200 |
2018/03/08 | 3,650 | 3,730 | 3,625 | 3,720 | +130 | +3.6% | 378,100 |
2018/03/07 | 3,550 | 3,610 | 3,540 | 3,590 | +50 | +1.4% | 218,400 |
2018/03/06 | 3,515 | 3,550 | 3,485 | 3,540 | +50 | +1.4% | 163,700 |
1701~
1750
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 433,100円 | +20.9% | +87.3% | 3.14% | 9.67倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 435,700円 | +5.8% | +1.2% | 2.75% | 14.45倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 92,200円 | +26.8% | - | 0.00% | 15.52倍 | 3.21倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 189,400円 | +5.0% | +1.5% | 0.00% | 16.26倍 | 4.33倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 341,400円 | +7.9% | +8.9% | 3.63% | 7.30倍 | 0.98倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム